European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Prebiotic claim awarded for inulin and oligofructose in Indonesia May 19, 2021 Australian Trial Examines Impact of HAMSAB (Resistant Starch-based) Prebiotic and Patients with High Blood Pressure January 11, 2023 Noninvasive imaging and quantification of bile salt hydrolase activity: From bacteria to humans February 8, 2021
Australian Trial Examines Impact of HAMSAB (Resistant Starch-based) Prebiotic and Patients with High Blood Pressure January 11, 2023
Noninvasive imaging and quantification of bile salt hydrolase activity: From bacteria to humans February 8, 2021